BDX
Price
$172.94
Change
+$1.91 (+1.12%)
Updated
Jun 6, 04:11 PM (EDT)
Capitalization
71.49B
62 days until earnings call
SRDX
Price
$29.45
Change
-$0.35 (-1.17%)
Updated
Jun 6, 02:49 PM (EDT)
Capitalization
397.04M
54 days until earnings call
Interact to see
Advertisement

BDX vs SRDX

Header iconBDX vs SRDX Comparison
Open Charts BDX vs SRDXBanner chart's image
Becton Dickinson and
Price$172.94
Change+$1.91 (+1.12%)
Volume$807
Capitalization71.49B
Surmodics
Price$29.45
Change-$0.35 (-1.17%)
Volume$300
Capitalization397.04M
BDX vs SRDX Comparison Chart
Loading...
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDX vs. SRDX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and SRDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BDX: $171.03 vs. SRDX: $29.77)
Brand notoriety: BDX and SRDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BDX: 89% vs. SRDX: 69%
Market capitalization -- BDX: $71.49B vs. SRDX: $397.04M
BDX [@Medical Specialties] is valued at $71.49B. SRDX’s [@Medical Specialties] market capitalization is $397.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green whileSRDX’s FA Score has 0 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • SRDX’s FA Score: 0 green, 5 red.
According to our system of comparison, BDX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish while SRDX’s TA Score has 5 bullish TA indicator(s).

  • BDX’s TA Score: 5 bullish, 3 bearish.
  • SRDX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than BDX.

Price Growth

BDX (@Medical Specialties) experienced а -1.61% price change this week, while SRDX (@Medical Specialties) price change was +0.81% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.07%. For the same industry, the average monthly price growth was +5.30%, and the average quarterly price growth was +1.75%.

Reported Earning Dates

BDX is expected to report earnings on Aug 07, 2025.

SRDX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+2.07% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDX($71.5B) has a higher market cap than SRDX($397M). SRDX has higher P/E ratio than BDX: SRDX (71.51) vs BDX (55.97). BDX (-24.270) and SRDX (-24.823) have similar YTD gains . BDX has higher annual earnings (EBITDA): 4.28B vs. SRDX (22.1M). BDX has more cash in the bank: 1.18B vs. SRDX (35.2M). SRDX has less debt than BDX: SRDX (33.9M) vs BDX (16.1B). BDX has higher revenues than SRDX: BDX (19.5B) vs SRDX (138M).
BDXSRDXBDX / SRDX
Capitalization71.5B397M18,010%
EBITDA4.28B22.1M19,380%
Gain YTD-24.270-24.82398%
P/E Ratio55.9771.5178%
Revenue19.5B138M14,130%
Total Cash1.18B35.2M3,358%
Total Debt16.1B33.9M47,493%
FUNDAMENTALS RATINGS
BDX vs SRDX: Fundamental Ratings
BDX
SRDX
OUTLOOK RATING
1..100
1027
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8192
PRICE GROWTH RATING
1..100
6459
P/E GROWTH RATING
1..100
8893
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (6) in the Medical Specialties industry is significantly better than the same rating for SRDX (92). This means that BDX’s stock grew significantly faster than SRDX’s over the last 12 months.

BDX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

BDX's SMR Rating (81) in the Medical Specialties industry is in the same range as SRDX (92). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (59) in the Medical Specialties industry is in the same range as BDX (64). This means that SRDX’s stock grew similarly to BDX’s over the last 12 months.

BDX's P/E Growth Rating (88) in the Medical Specialties industry is in the same range as SRDX (93). This means that BDX’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXSRDX
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
Bearish Trend 5 days ago
40%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
49%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
30%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSS8.570.44
+5.41%
Kohls Corp
TS34.560.06
+0.17%
Tenaris S A
CING4.24N/A
+0.12%
Cingulate Inc
ALCO31.25-0.16
-0.51%
Alico
CNS75.10-0.64
-0.84%
Cohen & Steers

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TMO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+0.05%
TMO - BDX
49%
Loosely correlated
-1.31%
CNMD - BDX
48%
Loosely correlated
+0.09%
STE - BDX
46%
Loosely correlated
+0.61%
HOLX - BDX
44%
Loosely correlated
+0.82%
RVTY - BDX
43%
Loosely correlated
-2.06%
More